- The Wall Street Journal•4 hours ago
The chief executive of a Canadian drugmaker is suing a noted short seller for libel after the investor criticized the CEO’s tenure at another drug company, which earlier settled charges of accounting fraud....
- Insider Monkey•17 hours agoBiotech Week In Review: Valeant, Progenics, Relistor and Vesneo – Valeant Pharmaceuticals Intl Inc (VRX) Progenics Pharmaceuticals, Inc. (PGNX)
Last week, the FDA had two major decisions to make regarding troubled drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The first was whether or not to approve Relistor, a combined effort between Valeant and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). The second, the same decision for Vesneo, a glaucoma drug that Valeant has developed by way of […]
Valeant Pharmaceuticals International, Inc.Toronto
|52wk Range||24.32 - 347.84|
|Day's Range||28.99 - 30.20|
|Avg Vol (3m)||1,261,809|
As of 3:59 PM EDT. Market closed.